Chang Vivian Y, He Yuwei, Grohe Samantha, Brady Morgan R, Chan Aldi, Kadam Rucha S, Fang Tiancheng, Pang Amara, Pohl Katherine, Tran Evelyn, Li Michelle, Kan Jenny, Zhang Yurun, Lu Josie J, Sasine Joshua P, Himburg Heather A, Yue Peibin, Chute John P
Division of Hematology-Oncology, Department of Pediatrics, UCLA, Los Angeles, CA, USA.
Children's Discovery and Innovation Institute, UCLA, Los Angeles, CA, USA.
iScience. 2024 Jun 19;27(7):110306. doi: 10.1016/j.isci.2024.110306. eCollection 2024 Jul 19.
Hematopoietic aging is associated with decreased hematopoietic stem cell (HSC) self-renewal capacity and myeloid skewing. We report that culture of bone marrow (BM) HSCs from aged mice with epidermal growth factor (EGF) suppressed myeloid skewing, increased multipotent colony formation, and increased HSC repopulation in primary and secondary transplantation assays. Mice transplanted with aged, EGF-treated HSCs displayed increased donor cell engraftment within BM HSCs and systemic administration of EGF to aged mice increased HSC self-renewal capacity in primary and secondary transplantation assays. Expression of a dominant negative EGFR in Scl/Tal1 hematopoietic cells caused increased myeloid skewing and depletion of long term-HSCs in 15-month-old mice. EGF treatment decreased DNA damage in aged HSCs and shifted the transcriptome of aged HSCs from genes regulating cell death to genes involved in HSC self-renewal and DNA repair but had no effect on HSC senescence. These data suggest that EGFR signaling regulates the repopulating capacity of aged HSCs.
造血衰老与造血干细胞(HSC)自我更新能力下降和髓系偏向有关。我们报告称,用表皮生长因子(EGF)培养老年小鼠的骨髓(BM)造血干细胞可抑制髓系偏向,增加多能集落形成,并在初次和二次移植试验中增强造血干细胞的再增殖能力。移植了经EGF处理的老年造血干细胞的小鼠,其骨髓造血干细胞内的供体细胞植入增加,并且对老年小鼠进行EGF全身给药可在初次和二次移植试验中增强造血干细胞的自我更新能力。在Scl/Tal1造血细胞中表达显性负性表皮生长因子受体(EGFR)会导致15月龄小鼠的髓系偏向增加和长期造血干细胞耗竭。EGF处理可减少老年造血干细胞中的DNA损伤,并使老年造血干细胞的转录组从调节细胞死亡的基因转变为参与造血干细胞自我更新和DNA修复的基因,但对造血干细胞衰老没有影响。这些数据表明,EGFR信号传导调节老年造血干细胞的再增殖能力。